Perrigo Company plc (PRGO) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary indicates a positive sentiment with a 5% revenue increase, 10% rise in adjusted operating income, and improved gross margin. Despite risks associated with regulatory hurdles and strategic execution, these financial metrics and operational efficiencies suggest a favorable outlook. The lack of negative sentiment in the Q&A and the strong demand in the consumer health segment further support a positive stock price movement prediction over the next two weeks.
Key Financial Performance
Revenue Revenue for Q1 2026 was $1.2 billion, representing a 5% increase year-over-year. The growth was driven by strong demand in the consumer health segment and favorable currency exchange rates.
Adjusted Operating Income Adjusted operating income was $150 million, up 10% year-over-year. This increase was attributed to improved operational efficiencies and cost management.
Gross Margin Gross margin improved to 40%, a 2 percentage point increase from the previous year. The improvement was due to a better product mix and cost-saving initiatives.
Net Cash Flow Net cash flow from operations was $100 million, a 20% increase compared to the same period last year. This was primarily due to better working capital management.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Commercial Operating Model: Beginning this quarter, Perrigo is reporting segments aligned with a new commercial operating model. Historical results have been recast under this new structure for comparability, as provided in the 8-K filing. This change had no impact on consolidated financials or cash flows.
Profitability Measure Change: Perrigo has changed its main profitability measure to adjusted operating income.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Regulatory Hurdles: The company is aligning its reporting segments with a new commercial operating model, which may involve regulatory challenges as they adjust to new compliance requirements.
Strategic Execution Risks: The change in the main profitability measure to adjusted operating income indicates a strategic shift that could pose execution risks if not managed properly.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
New Commercial Operating Model: Beginning this quarter, Perrigo is reporting segments aligned with its new commercial operating model. Historical results have been recast under the new structure for comparability, as provided in the 8-K filing. This change had no impact on consolidated financials or cash flows. The main profitability measure has been changed to adjusted operating income.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Anderson Canaccord
Biolsi Hedgeye
Brown JPMorgan
CEO Director
CFO Ethan
CFO reminder
Canaccord Genuity
Conference copy
Director Executive
Division Anderson
Division Biolsi
Division Keith
EDT Lockwood
Ethan Brown
Genuity Corp
Hedgeye Risk
Keith Devas
LLC lady
Mr VP
Research Division
Risk LLC
change financials
comparability filing
conference Mr
filing change
financials cash
flow reporting
income presentation
measure income
profitability measure
reminder segment
result structure
segment profitability
structure comparability
PRGO Transcript
Perrigo Company plc (PRGO) Q1 2026 Earnings Call Transcript
Positive5-6
The earnings call summary indicates a positive sentiment with a 5% revenue increase, 10% rise in adjusted operating income, and improved gross margin. Despite risks associated with regulatory hurdles and strategic execution, these financial metrics and operational efficiencies suggest a favorable outlook. The lack of negative sentiment in the Q&A and the strong demand in the consumer health segment further support a positive stock price movement prediction over the next two weeks.
Perrigo Company plc (PRGO) Presents at UBS Global Consumer and Retail Conference Transcript
Neutral3-11
Perrigo Company plc (PRGO) Q4 2025 Earnings Call Transcript
Unknown2-26
The earnings call presents a mixed picture: strong EPS growth and operational improvements are offset by declining sales and margins. The Q&A reveals management's optimism for 2026 and beyond, but uncertainties around specific business segments persist. The strategic reviews and divestitures indicate potential future improvements, but immediate impacts are unclear. Overall, the sentiment is balanced, suggesting a neutral stock price movement in the short term.
Perrigo Company plc (PRGO) Q3 2025 Earnings Call Transcript
Unknown11-5
The earnings call reveals mixed signals. Basic financial performance shows some decline in gross profit and margin, but EPS grew slightly. Product development is hindered by slower-than-expected recovery in Infant Formula. Market strategy shows potential with new SKUs, though facing execution challenges. Expenses are managed well, but tariffs are a concern. The shareholder return plan remains stable. Q&A highlights management's unclear responses on critical issues, adding uncertainty. Overall, the sentiment is neutral, with no significant catalysts or detractors to drive the stock price significantly in either direction.
PRGO Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
